With a fresh leadership team settling in, CNS Pharmaceuticals is wiping its pipeline clean as it hunts for a new lead asset in a strategic pivot.
- Home |
- CNS Pharma wipes glioblastoma pipeline clean in strategic pivot to fresh neurology, oncology targets
CNS Pharma wipes glioblastoma pipeline clean in strategic pivot to fresh neurology, oncology targets
- March 11, 2026
Recent Posts
- LNG market tightens into winter as Europe pulls US cargoes, China reopens contract talks
- EIA: US crude oil inventories down 3.2 million bbl
- Chevron restructures Bakken midstream agreements, transfers Hess Midstream stake
- Cenovus to build oil sands business via Athabasca acquisition
- Centalion acquires Haynesville gas assets from Silver Hill
